Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
12 Nov 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of HS-10382 Tablets in Healthy ParticipantsPhase 1Not Yet Recruiting12 Nov 2026Liaoning Chengda Biotechnology CO., LTDChinaImmunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Patients Infected With Human Immunodeficiency Virus (HIV)Phase 4Recruiting12 Nov 2026Novelty Nobility, Inc.ChinaA Study of NN2802, an Anti-c-Kit Antibody, in Healthy Participants and in Adults With Chronic Spontaneous Urticaria (CSU)Phase 1, Phase 2Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, China, JapanA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExercisePhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Qilu Pharmaceutical Co., Ltd.ChinaPhase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting12 Nov 2026Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.ChinaA Phase I of FXS0260 in Advanced Solid TumorPhase 1Not Yet Recruiting10 Nov 2026Beijing Inno Medicine Co., Ltd.United States, ChinaA Phase I Clinical Study of YN003 in the Treatment of GliomaPhase 1Recruiting10 Nov 2026Beijing Supreme Life Pharmaceutical Technology Co., Ltd.ChinaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Inadequate Glycemic Control on Metformin TherapyPhase 2Not Yet Recruiting10 Nov 2026Hangzhou Sciwind Biosciences Co., Ltd.ChinaA Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityPhase 2Not Yet Recruiting10 Nov 2026Minghui Pharmaceutical (Shanghai) LTDChinaA Clinical Study of MHB034C for Injection in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting10 Nov 2026Shenzhen NewDEL Biotech, Co., LtdChinaA Phase Ⅱa Study of ND-003 Tablets in Patients With Idiopathic Pulmonary FibrosisPhase 2Enrolling By Invitation10 Nov 2026Vigonvita Life SciencesChinaStudy of Food Effects of VV261 Tablets in Healthy Trial ParticipantsPhase 1Not Yet Recruiting10 Nov 2026Xiamen Amoytop Biotech Co., Ltd.ChinaACT201 Injection in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog Therapy - Phase IbPhase 1Not Yet Recruiting9 Nov 2026Amway (China) R&D CenterChinaExplore the Weight Loss Effect of Amway "BODY TRIMMER"Not applicableRecruiting9 Nov 2026Beijing InnoCare Pharma Tech Co., Ltd.ChinaA Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) PatientsPhase 3Recruiting9 Nov 2026CSPC Megalith Biopharmaceutical Co.,Ltd.ChinaA Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal CarcinomaPhase 3Recruiting9 Nov 2026Triastek, lnc.ChinaA Pharmacokinetic Study of Budesonide Delayed Release Tablet D23A (D23) in Healthy Chinese Participants Under Fasting ConditionsPhase 1Active Not Recruiting6 Nov 2026AstraZenecaChina, IndiaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesPhase 3Not Yet Recruiting6 Nov 2026Beijing Pins Medical Co., LtdChinaClinical Trial of SEEG for Drug-resistant EpilepsyNot applicableNot Yet Recruiting6 Nov 2026Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.ChinaA Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid TumorsPhase 1Recruiting6 Nov 2026Chengdu SciMount Pharmatech Co., Ltd.ChinaA First-in-human Study of SMP-656 in Subjects With Locally Advanced/ Metastatic HER2 Expressing or Mutated Solid TumorsPhase 1Completed6 Nov 2026Gan & Lee Pharmaceuticals.ChinaA Phase I Study of GLR2053 Tablets in Chinese Healthy Adult ParticipantsPhase 1Not Yet Recruiting6 Nov 2026Guangdong Hengrui Pharmaceutical Co., LtdChinaA Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar PustulosisPhase 2Not Yet Recruiting6 Nov 2026Hexin (Suzhou) Pharmaceutical Technology Co., LtdChinaEvaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid TumorsPhase 1Enrolling By Invitation6 Nov 2026Hexin (Suzhou) Pharmaceutical Technology Co., LtdChinaA Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT ImagingPhase 2Recruiting6 Nov 2026Huabo Biopharm Co., Ltd.ChinaA Study of HB0017 Injection in Healthy Volunteers to Evaluate Safety and Tolerability of a Single Subcutaneous Injection in Low-Body-Weight Subjects; and Pharmacokinetics at Different Subcutaneous Injection Sites at the Same DosePhase 1Recruiting6 Nov 2026Jiangsu HengRui Medicine Co., Ltd.ChinaEfficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 DiabetesPhase 3Not Yet Recruiting6 Nov 2026Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaA Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes MellitusPhase 2Not Yet Recruiting6 Nov 2026Techpool Bio-Pharma Co., Ltd.ChinaPharmacokinetics, Safety and Tolerability of Single Sequential and Multiple Intravenous Infusions of Ulinastatin for Injection in Healthy Chinese ParticipantsPhase 1Not Yet Recruiting6 Nov 2026The United Bio-Technology (Hengqin) Co., Ltd.ChinaA Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy ParticipantsPhase 1Not Yet Recruiting5 Nov 2026Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.ChinaClinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)Phase 1, Phase 2Recruiting5 Nov 2026Beijing Supreme Life Pharmaceutical Technology Co., Ltd.ChinaFuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle InterventionPhase 2Not Yet Recruiting5 Nov 2026BrightGene Bio-Medical Technology Co., Ltd.ChinaA Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without DiabetesPhase 2Not Yet Recruiting5 Nov 2026Gan & Lee Pharmaceuticals.ChinaComparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin AspartPhase 1Recruiting5 Nov 2026Jiangsu Chuangyuan Life Science and Technology Co., Ltd.ChinaCPU-YL01 Injection in Patients With Chronic Hepatitis B.Phase 1Enrolling By Invitation4 Nov 2026Beijing Gene Key Life Technology Co., LtdChinaA Study of GKL-006Allo Injection in Patients With Ankylosing SpondylitisPhase 1Not Yet Recruiting4 Nov 2026Beijing QL Biopharmaceutical Co.,LtdChinaA Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsPhase 1Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting4 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaPhase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese ParticipantsPhase 1Recruiting4 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal ImpairmentPhase 1Recruiting4 Nov 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaSintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal CancerPhase 3Not Yet Recruiting4 Nov 2026InnovStone Therapeutics LimitedChinaSYH2072 Tablets in Participants With Primary AldosteronismPhase 2Not Yet Recruiting4 Nov 2026REMD Medical TechnologyChinaA Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver TumorsNot applicableCompleted4 Nov 2026Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.ChinaA Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.Phase 3Not Yet Recruiting3 Nov 2026Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.ChinaStudy of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)Phase 2Not Yet Recruiting3 Nov 2026CSPC ZhongQi Pharmaceutical Technology Co., Ltd.ChinaA Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting3 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic ImpairmentPhase 1Recruiting3 Nov 2026Hunan Kelun Pharmaceutical Co., Ltd.ChinaA Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial ParticipantsPhase 1Not Yet Recruiting// How AOS uses this